Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 329 entries
Sorted by: Best Match Show Resources per page
Mapping the Spatiotemporal Evolution of Emotional Processing: An MEG Study Across Arousal and Valence Dimensions.

Frontiers in human neuroscience

Styliadis C, Ioannides AA, Bamidis PD, Papadelis C.
PMID: 30147649
Front Hum Neurosci. 2018 Aug 10;12:322. doi: 10.3389/fnhum.2018.00322. eCollection 2018.

Electrophysiological and functional neuroimaging findings indicate that the neural mechanisms underlying the processing of emotional dimensions (i.e., valence, arousal) constitute a spatially and temporally distributed emotional network, modulated by the arousal and/or valence of the emotional stimuli. We examined...

Cite
Styliadis C, Ioannides AA, Bamidis PD, et al. Mapping the Spatiotemporal Evolution of Emotional Processing: An MEG Study Across Arousal and Valence Dimensions. Front Hum Neurosci. 2018;12:322doi: 10.3389/fnhum.2018.00322.
Styliadis, C., Ioannides, A. A., Bamidis, P. D., & Papadelis, C. (2018). Mapping the Spatiotemporal Evolution of Emotional Processing: An MEG Study Across Arousal and Valence Dimensions. Frontiers in human neuroscience, 12322. https://doi.org/10.3389/fnhum.2018.00322
Styliadis, Charis, et al. "Mapping the Spatiotemporal Evolution of Emotional Processing: An MEG Study Across Arousal and Valence Dimensions." Frontiers in human neuroscience vol. 12 (2018): 322. doi: https://doi.org/10.3389/fnhum.2018.00322
Styliadis C, Ioannides AA, Bamidis PD, Papadelis C. Mapping the Spatiotemporal Evolution of Emotional Processing: An MEG Study Across Arousal and Valence Dimensions. Front Hum Neurosci. 2018 Aug 10;12:322. doi: 10.3389/fnhum.2018.00322. eCollection 2018. PMID: 30147649; PMCID: PMC6096200.
Copy Download .nbib Format: NLM
Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis.

Frontiers in surgery

Ioannidis O, Kitsikosta L, Tatsis D, Skandalos I, Cheva A, Gkioti A, Varnalidis I, Symeonidis S, Savvala NA, Parpoudi S, Paraskevas GK, Pramateftakis MG, Kotidis E, Mantzoros I, Tsalis KG.
PMID: 28740847
Front Surg. 2017 Jul 10;4:36. doi: 10.3389/fsurg.2017.00036. eCollection 2017.

BACKGROUND: Fournier's gangrene (FG) is a rapidly evolving necrotizing fasciitis of the perineum and the genital area, the scrotum as it most commonly affects man in the vast majority of cases. It is polymicrobial in origin, due to the...

Cite
Ioannidis O, Kitsikosta L, Tatsis D, et al. Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis. Front Surg. 2017;4:36doi: 10.3389/fsurg.2017.00036.
Ioannidis, O., Kitsikosta, L., Tatsis, D., Skandalos, I., Cheva, A., Gkioti, A., Varnalidis, I., Symeonidis, S., Savvala, N. A., Parpoudi, S., Paraskevas, G. K., Pramateftakis, M. G., Kotidis, E., Mantzoros, I., & Tsalis, K. G. (2017). Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis. Frontiers in surgery, 436. https://doi.org/10.3389/fsurg.2017.00036
Ioannidis, Orestis, et al. "Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis." Frontiers in surgery vol. 4 (2017): 36. doi: https://doi.org/10.3389/fsurg.2017.00036
Ioannidis O, Kitsikosta L, Tatsis D, Skandalos I, Cheva A, Gkioti A, Varnalidis I, Symeonidis S, Savvala NA, Parpoudi S, Paraskevas GK, Pramateftakis MG, Kotidis E, Mantzoros I, Tsalis KG. Fournier's Gangrene: Lessons Learned from Multimodal and Multidisciplinary Management of Perineal Necrotizing Fasciitis. Front Surg. 2017 Jul 10;4:36. doi: 10.3389/fsurg.2017.00036. eCollection 2017. PMID: 28740847; PMCID: PMC5502266.
Copy Download .nbib Format: NLM
Isolation of .

New microbes and new infections

Patas K, Douros K, Priftis KN, Ioannidis A, Nikolaou C, Chatzipanagiotou S.
PMID: 30899518
New Microbes New Infect. 2019 Feb 07;29:100509. doi: 10.1016/j.nmni.2019.01.005. eCollection 2019 May.

We report a rare case of non-cystic fibrosis bronchiectasis accompanied by protracted infection with

Cite
Patas K, Douros K, Priftis KN, et al. Isolation of . New Microbes New Infect. 2019;29:100509doi: 10.1016/j.nmni.2019.01.005.
Patas, K., Douros, K., Priftis, K. N., Ioannidis, A., Nikolaou, C., & Chatzipanagiotou, S. (2019). Isolation of . New microbes and new infections, 29100509. https://doi.org/10.1016/j.nmni.2019.01.005
Patas, K, et al. "Isolation of ." New microbes and new infections vol. 29 (2019): 100509. doi: https://doi.org/10.1016/j.nmni.2019.01.005
Patas K, Douros K, Priftis KN, Ioannidis A, Nikolaou C, Chatzipanagiotou S. Isolation of . New Microbes New Infect. 2019 Feb 07;29:100509. doi: 10.1016/j.nmni.2019.01.005. eCollection 2019 May. PMID: 30899518; PMCID: PMC6406053.
Copy Download .nbib Format: NLM
A huge asymptomatic pheochromocytoma.

Clinical case reports

Machairas N, Papaconstantinou D, Papala A, Ioannidis A, Patapis P, Misiakos EP.
PMID: 29988674
Clin Case Rep. 2018 May 08;6(7):1366-1367. doi: 10.1002/ccr3.1566. eCollection 2018 Jul.

Due to their evolution in the retroperitoneal space, pheochromocytomas may grow significantly in size and remain asymptomatic for a long period of time. Normal values of urine catecholamine levels must not preclude the diagnosis of these endocrine lesions.

Cite
Machairas N, Papaconstantinou D, Papala A, et al. A huge asymptomatic pheochromocytoma. Clin Case Rep. 2018;6(7):1366-1367doi: 10.1002/ccr3.1566.
Machairas, N., Papaconstantinou, D., Papala, A., Ioannidis, A., Patapis, P., & Misiakos, E. P. (2018). A huge asymptomatic pheochromocytoma. Clinical case reports, 6(7), 1366-1367. https://doi.org/10.1002/ccr3.1566
Machairas, Nikolaos, et al. "A huge asymptomatic pheochromocytoma." Clinical case reports vol. 6,7 (2018): 1366-1367. doi: https://doi.org/10.1002/ccr3.1566
Machairas N, Papaconstantinou D, Papala A, Ioannidis A, Patapis P, Misiakos EP. A huge asymptomatic pheochromocytoma. Clin Case Rep. 2018 May 08;6(7):1366-1367. doi: 10.1002/ccr3.1566. eCollection 2018 Jul. PMID: 29988674; PMCID: PMC6028367.
Copy Download .nbib Format: NLM
Optimizing Resource Allocation in a Cowpea (.

Frontiers in plant science

Omirou M, Ioannides IM, Fasoula DA.
PMID: 31440264
Front Plant Sci. 2019 Aug 07;10:949. doi: 10.3389/fpls.2019.00949. eCollection 2019.

Cowpea is a warm-season legume, often characterized as an orphan or underutilized crop, with great future potential, particularly under the global change. A traditional cowpea landrace in Cyprus is highly valued for fresh pod consumption in the local cuisine....

Cite
Omirou M, Ioannides IM, Fasoula DA. Optimizing Resource Allocation in a Cowpea (. Front Plant Sci. 2019;10:949doi: 10.3389/fpls.2019.00949.
Omirou, M., Ioannides, I. M., & Fasoula, D. A. (2019). Optimizing Resource Allocation in a Cowpea (. Frontiers in plant science, 10949. https://doi.org/10.3389/fpls.2019.00949
Omirou, Michalis, et al. "Optimizing Resource Allocation in a Cowpea (." Frontiers in plant science vol. 10 (2019): 949. doi: https://doi.org/10.3389/fpls.2019.00949
Omirou M, Ioannides IM, Fasoula DA. Optimizing Resource Allocation in a Cowpea (. Front Plant Sci. 2019 Aug 07;10:949. doi: 10.3389/fpls.2019.00949. eCollection 2019. PMID: 31440264; PMCID: PMC6694199.
Copy Download .nbib Format: NLM
Management of MANEC of the colon and rectum: A comprehensive review of the literature.

Molecular and clinical oncology

Paspala A, Machairas N, Prodromidou A, Spartalis E, Ioannidis A, Kostakis ID, Papaconstantinou D, Nikiteas N.
PMID: 30101026
Mol Clin Oncol. 2018 Aug;9(2):219-222. doi: 10.3892/mco.2018.1649. Epub 2018 Jun 11.

Mixed adeno-neuroendocrine carcinoma (MANEC) is a rare pathological diagnosis recently acknowledged by the World Health Organization in 2010. MANEC is a neoplasm characterized by significant histological heterogeneity and is characterized by the simultaneous presence of both adenocarcinomatous and neuroendocrine...

Cite
Paspala A, Machairas N, Prodromidou A, et al. Management of MANEC of the colon and rectum: A comprehensive review of the literature. Mol Clin Oncol. 2018;9(2):219-222doi: 10.3892/mco.2018.1649.
Paspala, A., Machairas, N., Prodromidou, A., Spartalis, E., Ioannidis, A., Kostakis, I. D., Papaconstantinou, D., & Nikiteas, N. (2018). Management of MANEC of the colon and rectum: A comprehensive review of the literature. Molecular and clinical oncology, 9(2), 219-222. https://doi.org/10.3892/mco.2018.1649
Paspala, Anna, et al. "Management of MANEC of the colon and rectum: A comprehensive review of the literature." Molecular and clinical oncology vol. 9,2 (2018): 219-222. doi: https://doi.org/10.3892/mco.2018.1649
Paspala A, Machairas N, Prodromidou A, Spartalis E, Ioannidis A, Kostakis ID, Papaconstantinou D, Nikiteas N. Management of MANEC of the colon and rectum: A comprehensive review of the literature. Mol Clin Oncol. 2018 Aug;9(2):219-222. doi: 10.3892/mco.2018.1649. Epub 2018 Jun 11. PMID: 30101026; PMCID: PMC6083408.
Copy Download .nbib Format: NLM
Costoclavicular Joint: An Osteological Study on Clavicles with Clinical Relevance.

Cureus

Paraskevas GK, Koutsouflianiotis KN, Iliou K, Syrmos N, Ioannidis O, Noussios G.
PMID: 31245198
Cureus. 2019 Apr 08;11(4):e4409. doi: 10.7759/cureus.4409.

Introduction The current study aims to detect the incidence of occurrence of a morphological variant of the impression for the costoclavicular ligament, that is a faceted apophysis of the clavicle which participates in the formation of an aberrant joint,...

Cite
Paraskevas GK, Koutsouflianiotis KN, Iliou K, et al. Costoclavicular Joint: An Osteological Study on Clavicles with Clinical Relevance. Cureus. 2019;11(4):e4409doi: 10.7759/cureus.4409.
Paraskevas, G. K., Koutsouflianiotis, K. N., Iliou, K., Syrmos, N., Ioannidis, O., & Noussios, G. (2019). Costoclavicular Joint: An Osteological Study on Clavicles with Clinical Relevance. Cureus, 11(4), e4409. https://doi.org/10.7759/cureus.4409
Paraskevas, George K, et al. "Costoclavicular Joint: An Osteological Study on Clavicles with Clinical Relevance." Cureus vol. 11,4 (2019): e4409. doi: https://doi.org/10.7759/cureus.4409
Paraskevas GK, Koutsouflianiotis KN, Iliou K, Syrmos N, Ioannidis O, Noussios G. Costoclavicular Joint: An Osteological Study on Clavicles with Clinical Relevance. Cureus. 2019 Apr 08;11(4):e4409. doi: 10.7759/cureus.4409. PMID: 31245198; PMCID: PMC6559695.
Copy Download .nbib Format: NLM
Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy.

Frontiers in neurology

Ioannides ZA, Csurhes PA, Douglas NL, Mackenroth G, Swayne A, Thompson KM, Hopkins TJ, Green KA, Blum S, Hooper KD, Wyssusek KH, Coulthard A, Pender MP.
PMID: 33790852
Front Neurol. 2021 Mar 15;12:652811. doi: 10.3389/fneur.2021.652811. eCollection 2021.

No abstract available.

Cite
Ioannides ZA, Csurhes PA, Douglas NL, et al. Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy. Front Neurol. 2021;12:652811doi: 10.3389/fneur.2021.652811.
Ioannides, Z. A., Csurhes, P. A., Douglas, N. L., Mackenroth, G., Swayne, A., Thompson, K. M., Hopkins, T. J., Green, K. A., Blum, S., Hooper, K. D., Wyssusek, K. H., Coulthard, A., & Pender, M. P. (2021). Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy. Frontiers in neurology, 12652811. https://doi.org/10.3389/fneur.2021.652811
Ioannides, Zara A, et al. "Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy." Frontiers in neurology vol. 12 (2021): 652811. doi: https://doi.org/10.3389/fneur.2021.652811
Ioannides ZA, Csurhes PA, Douglas NL, Mackenroth G, Swayne A, Thompson KM, Hopkins TJ, Green KA, Blum S, Hooper KD, Wyssusek KH, Coulthard A, Pender MP. Sustained Clinical Improvement in a Subset of Patients With Progressive Multiple Sclerosis Treated With Epstein-Barr Virus-Specific T Cell Therapy. Front Neurol. 2021 Mar 15;12:652811. doi: 10.3389/fneur.2021.652811. eCollection 2021. PMID: 33790852; PMCID: PMC8005645.
Copy Download .nbib Format: NLM
An in vitro comparison of the marginal and internal adaptation of ultrathin occlusal veneers made of 3D-printed zirconia, milled zirconia, and heat-pressed lithium disilicate.

The Journal of prosthetic dentistry

Ioannidis A, Park JM, Hüsler J, Bomze D, Mühlemann S, Özcan M.
PMID: 33741143
J Prosthet Dent. 2021 Mar 16; doi: 10.1016/j.prosdent.2020.09.053. Epub 2021 Mar 16.

STATEMENT OF PROBLEM: Whether additively produced zirconia could overcome problems with conventional computer-aided design and computer-aided manufacture (CAD-CAM) such as milling inaccuracies and provide accurate occlusal veneers is unclear.PURPOSE: The purpose of this in vitro study was to compare...

Cite
Ioannidis A, Park JM, Hüsler J, et al. An in vitro comparison of the marginal and internal adaptation of ultrathin occlusal veneers made of 3D-printed zirconia, milled zirconia, and heat-pressed lithium disilicate. J Prosthet Dent. 2021;doi: 10.1016/j.prosdent.2020.09.053.
Ioannidis, A., Park, J. M., Hüsler, J., Bomze, D., Mühlemann, S., & Özcan, M. (2021). An in vitro comparison of the marginal and internal adaptation of ultrathin occlusal veneers made of 3D-printed zirconia, milled zirconia, and heat-pressed lithium disilicate. The Journal of prosthetic dentistry, . https://doi.org/10.1016/j.prosdent.2020.09.053
Ioannidis, Alexis, et al. "An in vitro comparison of the marginal and internal adaptation of ultrathin occlusal veneers made of 3D-printed zirconia, milled zirconia, and heat-pressed lithium disilicate." The Journal of prosthetic dentistry vol. (2021). doi: https://doi.org/10.1016/j.prosdent.2020.09.053
Ioannidis A, Park JM, Hüsler J, Bomze D, Mühlemann S, Özcan M. An in vitro comparison of the marginal and internal adaptation of ultrathin occlusal veneers made of 3D-printed zirconia, milled zirconia, and heat-pressed lithium disilicate. J Prosthet Dent. 2021 Mar 16; doi: 10.1016/j.prosdent.2020.09.053. Epub 2021 Mar 16. PMID: 33741143.
Copy Download .nbib Format: NLM
Benefits of not smoking during pregnancy for non-Aboriginal women and their babies in New South Wales, Australia: a record linkage study.

International journal of population data science

Patterson JA, Cashmore A, Ioannides S, Milat AJ, Nippita TA, Morris JM, Torvaldsen S.
PMID: 34970635
Int J Popul Data Sci. 2021 Dec 14;6(3):1699. doi: 10.23889/ijpds.v6i3.1699. eCollection 2021.

BACKGROUND: Smoking rates among pregnant women in New South Wales (NSW) have plateaued at 8-9%. To inform relevant smoking reduction efforts, we aimed to quantify the benefits of METHODS: This population-based cohort study used linked-data from routinely collected data...

Cite
Patterson JA, Cashmore A, Ioannides S, et al. Benefits of not smoking during pregnancy for non-Aboriginal women and their babies in New South Wales, Australia: a record linkage study. Int J Popul Data Sci. 2021;6(3):1699doi: 10.23889/ijpds.v6i3.1699.
Patterson, J. A., Cashmore, A., Ioannides, S., Milat, A. J., Nippita, T. A., Morris, J. M., & Torvaldsen, S. (2021). Benefits of not smoking during pregnancy for non-Aboriginal women and their babies in New South Wales, Australia: a record linkage study. International journal of population data science, 6(3), 1699. https://doi.org/10.23889/ijpds.v6i3.1699
Patterson, Jillian A, et al. "Benefits of not smoking during pregnancy for non-Aboriginal women and their babies in New South Wales, Australia: a record linkage study." International journal of population data science vol. 6,3 (2021): 1699. doi: https://doi.org/10.23889/ijpds.v6i3.1699
Patterson JA, Cashmore A, Ioannides S, Milat AJ, Nippita TA, Morris JM, Torvaldsen S. Benefits of not smoking during pregnancy for non-Aboriginal women and their babies in New South Wales, Australia: a record linkage study. Int J Popul Data Sci. 2021 Dec 14;6(3):1699. doi: 10.23889/ijpds.v6i3.1699. eCollection 2021. PMID: 34970635; PMCID: PMC8678976.
Copy Download .nbib Format: NLM
Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-Isolation and Related Risks.

Frontiers in psychiatry

Dores AR, Carvalho IP, Burkauskas J, Simonato P, De Luca I, Mooney R, Ioannidis K, Gómez-Martínez MÁ, Demetrovics Z, Ábel KE, Szabo A, Fujiwara H, Shibata M, Ventola ARM, Arroyo-Anlló EM, Santos-Labrador RM, Griskova-Bulanova I, Pranckeviciene A, Kobayashi K, Martinotti G, Fineberg NA, Barbosa F, Corazza O.
PMID: 33776822
Front Psychiatry. 2021 Mar 10;12:648501. doi: 10.3389/fpsyt.2021.648501. eCollection 2021.

No abstract available.

Cite
Dores AR, Carvalho IP, Burkauskas J, et al. Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-Isolation and Related Risks. Front Psychiatry. 2021;12:648501doi: 10.3389/fpsyt.2021.648501.
Dores, A. R., Carvalho, I. P., Burkauskas, J., Simonato, P., De Luca, I., Mooney, R., Ioannidis, K., Gómez-Martínez, M. �. �., Demetrovics, Z., Ábel, K. E., Szabo, A., Fujiwara, H., Shibata, M., Ventola, A. R. M., Arroyo-Anlló, E. M., Santos-Labrador, R. M., Griskova-Bulanova, I., Pranckeviciene, A., Kobayashi, K., Martinotti, G., Fineberg, N. A., Barbosa, F., & Corazza, O. (2021). Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-Isolation and Related Risks. Frontiers in psychiatry, 12648501. https://doi.org/10.3389/fpsyt.2021.648501
Dores, Artemisa R, et al. "Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-Isolation and Related Risks." Frontiers in psychiatry vol. 12 (2021): 648501. doi: https://doi.org/10.3389/fpsyt.2021.648501
Dores AR, Carvalho IP, Burkauskas J, Simonato P, De Luca I, Mooney R, Ioannidis K, Gómez-Martínez MÁ, Demetrovics Z, Ábel KE, Szabo A, Fujiwara H, Shibata M, Ventola ARM, Arroyo-Anlló EM, Santos-Labrador RM, Griskova-Bulanova I, Pranckeviciene A, Kobayashi K, Martinotti G, Fineberg NA, Barbosa F, Corazza O. Exercise and Use of Enhancement Drugs at the Time of the COVID-19 Pandemic: A Multicultural Study on Coping Strategies During Self-Isolation and Related Risks. Front Psychiatry. 2021 Mar 10;12:648501. doi: 10.3389/fpsyt.2021.648501. eCollection 2021. PMID: 33776822; PMCID: PMC7988429.
Copy Download .nbib Format: NLM
Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial.

Infectious diseases and therapy

Tsiakos K, Tsakiris A, Tsibris G, Voutsinas PM, Panagopoulos P, Kosmidou M, Petrakis V, Gravvani A, Gkavogianni T, Klouras E, Katrini K, Koufargyris P, Rapti I, Karageorgos A, Vrentzos E, Damoulari C, Zarkada V, Sidiropoulou C, Artemi S, Ioannidis A, Papapostolou A, Michelakis E, Georgiopoulou M, Myrodia DM, Tsiamalos P, Syrigos K, Chrysos G, Nitsotolis T, Milionis H, Poulakou G, Giamarellos-Bourboulis EJ.
PMID: 34363189
Infect Dis Ther. 2021 Dec;10(4):2333-2351. doi: 10.1007/s40121-021-00505-8. Epub 2021 Aug 06.

INTRODUCTION: The anti-inflammatory effect of macrolides prompted the study of oral clarithromycin in moderate COVID-19.METHODS: An open-label non-randomized trial in 90 patients with COVID-19 of moderate severity was conducted between May and October 2020. The primary endpoint was defined...

Cite
Tsiakos K, Tsakiris A, Tsibris G, et al. Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial. Infect Dis Ther. 2021;10(4):2333-2351doi: 10.1007/s40121-021-00505-8.
Tsiakos, K., Tsakiris, A., Tsibris, G., Voutsinas, P. M., Panagopoulos, P., Kosmidou, M., Petrakis, V., Gravvani, A., Gkavogianni, T., Klouras, E., Katrini, K., Koufargyris, P., Rapti, I., Karageorgos, A., Vrentzos, E., Damoulari, C., Zarkada, V., Sidiropoulou, C., Artemi, S., Ioannidis, A., Papapostolou, A., Michelakis, E., Georgiopoulou, M., Myrodia, D. M., Tsiamalos, P., Syrigos, K., Chrysos, G., Nitsotolis, T., Milionis, H., Poulakou, G., & Giamarellos-Bourboulis, E. J. (2021). Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial. Infectious diseases and therapy, 10(4), 2333-2351. https://doi.org/10.1007/s40121-021-00505-8
Tsiakos, Konstantinos, et al. "Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial." Infectious diseases and therapy vol. 10,4 (2021): 2333-2351. doi: https://doi.org/10.1007/s40121-021-00505-8
Tsiakos K, Tsakiris A, Tsibris G, Voutsinas PM, Panagopoulos P, Kosmidou M, Petrakis V, Gravvani A, Gkavogianni T, Klouras E, Katrini K, Koufargyris P, Rapti I, Karageorgos A, Vrentzos E, Damoulari C, Zarkada V, Sidiropoulou C, Artemi S, Ioannidis A, Papapostolou A, Michelakis E, Georgiopoulou M, Myrodia DM, Tsiamalos P, Syrigos K, Chrysos G, Nitsotolis T, Milionis H, Poulakou G, Giamarellos-Bourboulis EJ. Early Start of Oral Clarithromycin Is Associated with Better Outcome in COVID-19 of Moderate Severity: The ACHIEVE Open-Label Single-Arm Trial. Infect Dis Ther. 2021 Dec;10(4):2333-2351. doi: 10.1007/s40121-021-00505-8. Epub 2021 Aug 06. PMID: 34363189; PMCID: PMC8345236.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 329 entries